Repetitive Hits May Predispose Athletes to Concussion
TUESDAY, Nov. 13, 2018 -- Repetitive head impact exposure appears to be a predisposing factor for the onset of concussion, according to a study published online Oct. 22 in the Annals of Biomedical Engineering. Brian D. Stemper, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Understanding congenital heart defects to prevent them
(University of Houston) Cardiovascular failures are the leading cause of birth defect-related deaths in infants. To understand why congenital heart defects form, a University of Houston biomedical engineer is watching hearts develop with optical equipment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news

How Are Engineers Actually Using VR for Human Factors Review?
We've been hearing for some time now that virtual and augmented reality technologies are poised to revolutionize medtech, but can a VR system actually help R&D teams develop a medical device? It absolutely can, according to engineers at Cincinnati, OH-based Kaleidoscope Innovation. "When we've got a team that's maybe across the country or across the world, we can get in here and actually be in the same room virtually around the same product," Ben Ko, a biomedical engineer at Kaleidoscope, told MD&M Minneapolis attendees on Wednesday. Ko's colleague Jerry Schafer, a de...
Source: MDDI - October 31, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis R Source Type: news

Two-cells-in-one combo could be platform to bolster leukemia treatment
Researchers led by a UCLA bioengineer have developed a therapy — based on two types of cells joined into a single unit — that could help strengthen existing treatments for acute myeloid leukemia. One of the cells is a blood platelet that carries a drug that attacks cancer cells; the other is a stem cell that guides the platelet into bone marrow, the spongy tissue inside bone where new blood cells are made and where leukemia begins. The researchers found that when injected into mice that had acute myeloid leukemia, the combination therapy halted the disease from developing any further. Of the mice that received the tre...
Source: UCLA Newsroom: Health Sciences - October 29, 2018 Category: Universities & Medical Training Source Type: news

Medtech Mourns the Loss of Earl Bakken: Visionary, Humanist, Pioneer
Thousands of patients, clinicians, and medtech colleagues took to Twitter on Monday to honor the legacy of Earl Bakken. The co-founder of Medtronic and inventor of the first wearable external pacemaker, Bakken died Sunday in Hawaii at age 94. “All of us at Medtronic are saddened today by the news of Earl’s passing,” said Omar Ishrak, chairman and CEO of Medtronic. “Earl was a true pioneer in healthcare and his vision of using technology to help people still inspires us today. We are privileged to continue the work that he started over 60 ye...
Source: MDDI - October 23, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

This 13-Year-Old ’s Tool Could Change Pancreatic Cancer Treatment
An Oregon teenager’s innovation could change the way doctors treat pancreatic cancer, a deadly form of the disease that has just a 7% five-year survival rate. Rishab Jain, a 13-year-old from Stoller Middle School in Portland, on Tuesday won the Discovery Education 3M Young Scientist Challenge with an algorithm that uses machine learning to help doctors zero in on the pancreas during cancer treatment. Doing so can be difficult, since the pancreas is often obscured by other organs, and since breathing and other bodily processes can cause it to move around the abdominal area. As a result, doctors sometimes need to deplo...
Source: TIME: Health - October 19, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime onetime Source Type: news

The fine print
(University of Utah) University of Utah biomedical engineering assistant professor Robby Bowles and his team have developed a method to 3D print cells to produce human tissue such as ligaments and tendons to greatly improve a patient's recovery. A person with a badly damaged ligament, tendon, or ruptured disc could simply have new replacement tissue printed and ultimately implanted in the damaged area. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 10, 2018 Category: Biology Source Type: news

Latest research hints at predicting autism risk for pregnant mothers
(Rensselaer Polytechnic Institute) Researchers at Rensselaer Polytechnic Institute--led by Juergen Hahn, professor and head of biomedical engineering--are continuing to make remarkable progress with their research focused on autism spectrum disorder (ASD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 21, 2018 Category: International Medicine & Public Health Source Type: news

Trimedx picks up Aramark ’ s healthcare technologies business
Aramark (NYSE: ARMK) is quitting the healthcare technologies business, announcing today that it has agreed to sell that part of its business for $300 million to clinical engineering and asset management company Trimedx. Best known for its food service, uniform and facilities businesses, Aramark bought the Charlotte, N.C.-based healthcare business in 2001. It has been in operation for over 45 years and employs more than 1,500 technicians, engineers and program staff. Trimedx provides management programs for for maintenance and refurbishment of clinical equipment at more than 500 hospitals and healthcare facilities. “This ...
Source: Mass Device - September 17, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Wall Street Beat aramark trimedx Source Type: news

Watching an embryo's neural tube close
(University of Houston) A University of Houston biomedical engineer is tackling birth defects by creating new technology to peer into the neural tube of developing embryos, to solve the mystery of why some tubes close and others -- destined for trouble -- don't. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2018 Category: International Medicine & Public Health Source Type: news

Artificial cells are tiny bacteria fighters
(University of California - Davis) Artificial cells that can kill bacteria have been created by researchers at the UC Davis Department of Biomedical Engineering. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 31, 2018 Category: Infectious Diseases Source Type: news

Here & #039;s What MD+DI Readers Said About The Bleeding Edge
As part of MD+DI's coverage last week of the Netflix documentary, The Bleeding Edge, we asked readers for feedback on the film and its assessment of the medical device industry. A total of 62 respondents took the three-question survey.  1. The Bleeding Edge claims that FDA's 510(k) process, reportedly the most popular way medical devices reach the U.S. market, doesn’t require the submission of as much safety data as does the premarket approval (PMA) process. Do you believe this is a fair depiction? Of the 62 respondents who answered this question, 48 (77.42%) said yes, and just 14 ...
Source: MDDI - August 27, 2018 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Source Type: news

Assistive surgical devices shine in DEBUT biomedical engineering design competition
NIH and VentureWell award five undergraduate teams for innovative devices that improve medical procedures. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 24, 2018 Category: American Health Source Type: news

Stool proteins to predict inflammatory bowel disease
(University of Houston) A University of Houston biomedical engineer is looking for new biomarkers to predict and monitor inflammatory bowel disease (IBD). With $347,490 from the Crohn's& Colitis Foundation of America, Chandra Mohan says protein biomarkers that show up in stools could indicate the disease and make examination and treatment quicker and less invasive. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 20, 2018 Category: International Medicine & Public Health Source Type: news

Lessons learned: How Jeff Karp stays at the forefront of innovation
Serial entrepreneur Jeff Karp has a philosophy for his laboratory: find important problems and get solutions to people quickly. To learn about the exciting technologies emerging from Karp’s lab, join us at DeviceTalks Boston on Oct. 8-10. After Jeff finished his PhD in chemical and biomedical engineering at the University of Toronto, he knew he wanted to work with Robert Langer. “He’s the intergalactic translational superstar,” Karp said. Langer, a professor at the Massachusetts Institute of Technology and one of the most cited engineers of all time, receives thousands of applications per year from people looking ...
Source: Mass Device - August 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Research & Development DeviceTalks Boston Frequency Therapeutics Source Type: news